Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Endocrinology | Immunology | Nephrology

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Simulect

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Novartis
Approval Status: Approved May 1998
Treatment Area: acute organ transplant rejection

General Information

Simulect has been approved for acute rejection episodes in renal transplant recipients.

Mechanism of Action

Simulect works by blocking the receptor for IL-2, a protein that simulates proliferation of T-lymphocytes, which play a key role in organ transplant rejection.